Short Courses
 
SHORT COURSES - SUNDAY, 7 SEPTEMBER 2008

 

MORNING COURSES 8:00AM-12:00PM (All short courses are presented in English)

Introduction to Quality of Life Assessment/Patient Reported Outcomes
Faculty: Bruce Crawford MA, MPH, General Manager, Asia, Mapi Values, Tokyo, Japan; Watcharee Leurmarnkul PhD, Senior Research Pharmacist, Asia Pacific Department, Family Health International, Bangkok, Thailand
Course description: Definitions and concepts, methodologies, and practical methods for measuring patient reported outcomes will be presented. The value of patient reported outcomes assessment will be discussed.  A strategy to aid in selecting appropriate instruments and the translation processes will be presented.  Instrument development and validation will be discussed using practical examples and exercises. Designed for individuals with little experience with quality of life/PRO studies.
B. Crawford W. Leurmarnkul
B. Crawford W. Leurmarnkul
   
Introduction to Decision Analysis
Faculty: Shu-Chuen Li PhD, MS, MBA, Associate Professor, Department of Pharmacy, National University of Singapore, Singapore.
Course description: Decision analysis is a tool that uses an explicit, quantitative structure to describe and analyze complex health care decisions. This course will provide an introduction to the principles and practice of decision analysis. Upon completion of the course, participants will be able to evaluate the appropriateness of decision analysis in different settings, construct simple decision trees, understand the basic mechanics of tree evaluation and sensitivity analysis, and acquire skill in the interpretation of a published decision analysis. Extension of basic techniques, such as cost-effectiveness analysis and the assessment of patient preferences will be briefly discussed. Pen and paper exercises will be used to illustrate these principles. This course is suitable for those with little experience with decision analysis.
S. Li
S. Li
   
Meta-Analysis and Systematic Literature Review (Korean explanation is available if needed)
Faculty: Nathorn Chaiyakunapruk PharmD, PhD, Associate Professor, Department of Pharmacy Practice, School of Pharmacy, Naresuan University, Phitsanulok, 65000, Thailand; Suk-kyung Hahn PhD, Assistant Professor of Medical Statistics, Medical Research Collaborating Center, Seoul National University, Seoul, South Korea.
Course description: Meta-analysis may be defined as the statistical analysis of data from multiple studies for the purpose of synthesizing and summarizing results, as well as for quantitatively evaluating sources of heterogeneity and bias. A systematic literature review often includes meta-analysis and involves an explicit, detailed description of how a review was conducted. This course highlights and expounds upon four key areas: 1) impetus for meta-analysis and systematic reviews, 2) basic steps to perform a quantitative systematic review, 3) statistical methods of combining data, and 4) appraisal and use of meta-analytic reports. The material is motivated via applications in pharmacoeconomics, outcomes research, and clinical studies from the published literature and hypothetical examples. Interactive exercises are part of the course. This course is designed for those with little experience with meta-analysis.
N. Chaiyakunapruk S. Hahn
N. Chaiyakunapruk S. Hahn
   
Introduction to Biostatistics in Clinical Trials and Economic Studies (Korean explanation is available if needed)
Faculty: Isao Kamae MD, DrPH, Professor and Chair, Graduate School of Health Management, Keio University, Tokyo, Japan; Guk-Hee Suh MD, PhD, Professor of Psychiatry, Hallym University Medical Center, Hangang Sacred Heart Hospital, Seoul, South Korea.
Course description; This course provides an introduction to biostatistics and pharmacoeconomic analysis in clinical trials including the Bayesian approach. The topics will include elementary probability theory, basic concepts of statistical inference, sampling theory, hypothesis tests for randomized controlled trials, the power and sample size analysis, and introduction to the Bayesian statistics. Examples will be used to illustrate these methods in the context of cost-effectiveness analysis. This course will include a discussion of the “ISPOR Good Research Practices for Cost-Effectiveness Analysis alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report”. This course is to familiarize new researchers or managers interested in research with current statistical techniques so they will be able to use them both in their own research and to appreciate critically the work of others.
I. Kamae G. Suh
I. Kamae G. Suh
  A. Brnabic
  A. Brnabic
   
Pharmacoeconomics for Health Care Decision-makers
Faculty: Kenneth KC Lee JP, BSc(Pharm), MPhil, PhD, Professor, School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, P.R. China.
Course description: This course is designed to assist decision-making for health care workers. Participants will learn the basic concepts and tools for conducting pharmacoeconomics (PE) and outcomes research (OR). Different assessment methods including cost-effectiveness, cost-minimization, cost of illness, cost-utility and cost-benefit analysis will be discussed. Hands-on experience will be gained through practical exercises. The development of different economic models and utilization of published data will be introduced. The applications of PE and OR data will be covered and illustrated by practical examples. These will include formulary considerations, comparison of different clinical services, evaluation of different therapies etc. Decision analysis will be discussed and illustrated with examples. Participants will also be shown how to properly perform literature evaluation. Other related techniques including discounting, sensitivity analysis, protocol development, data collection etc will also be included. This course is designed for health care workers with brief knowledge and experience of PE and OR and are involved in decision making processes requiring economic considerations.
K. Lee
K. Lee
   
Formulary Development
Kenneth Hartigan-Go PhD, Executive Director, The Zuellig Foundation, Makati City, Philippine; You-Meei Lin, Assistant Director, Department of Pharmacy, Taipei Medical University - Wan Fang Hospital, Taipei, Taiwan
Course description: A drug formulary is a list of medications that are selected for use by a hospital. This course will describe the organizational structure of the P&T committee, the new drug application and review procedures, the preparation of drug monographs and description of the one-in and oneout process. There will be an in-depth discussion of the evidence-based practices with pharmacoeconomic consideration put into practice, the enforcement of drug formulary, the roles of key health care providers & policy decision-makers and the technology assessment responsibilities of the P&T. This course will employ real life examples. This course is designed for those with little experience in developing a formulary.
K. Hartigan-Go Y. Lin
K. Hartigan-Go Y. Lin
   
AFTERNOON COURSES 1:00PM-5:00PM (All short courses are presented in English)  
   

Budget Impact and Cost Analysis
Faculty: Gordon G. Liu PhD, Professor and Chair, Department of Health Economics and Management, Guanghua School of Management, Peking University, Beijing, P.R China
Course Description: This will describe methods to determine the cost-of-illness of a health condition. Participants will learn how to estimate the impact of new healthcare technologies on disease-specific costs from different decision-maker perspectives. Actuarial methods using straight-line projections and nonlinear trends will be described. Both static and dynamic methods for estimating the budget impact of reimbursing a new drug or technology by a health care system. This course is designed for those with some experience with pharmacoeconomic analysis.

G. Liu
G. Liu
 
Retrospective Data Analysis (Korean explanation is available if needed)
Faculty: Jeff J. Guo BPharm, PhD, Associate Professor, College of Pharmacy, Faculty Research Fellow, Institute for Health Policy and Health Service Research University of Cincinnati Medical Center, Cincinnati, OH, USA; Eui-Kyung Lee PhD, Professor, Sookmyung University, South Korea.
Course Description: Large administrative claims databases provide a unique opportunity to examine retrospectively the effects of drug use on clinical and economic outcomes in the “real world” settings. Retrospective data analysis, such as data from medical claims or the other health databases will be discussed. The advantages and disadvantages of using these datasets to perform economic analyses and epidemiologic studies will be outlined. This course will cover a discussion of the ISPOR Checklist for Retroactive Database Studies - Report of the ISPOR Task Force on Retrospective Databases and selected topics related to methodology, sampling, bias, and analysis. Several examples of retrospective database analyses related to pharmacoeconomics and outcomes research will be given. Participants will be given exercises related to their local or regional health database analysis and evaluation. This course is designed for those with little experience with database analysis. ISPOR Short Course, Introduction to Decision Analysis is a strong prerequisite for this course.
J. Guo E.K. Lee
J. Guo E.K. Lee
   
Elements of Pharmaceutical/Biotech Pricing
Faculty: Wayne Critchley, Partner, Gowling Lafleur Henderson LLP, Ottawa, ON, Canada; Jack Mycka, President and Partner, MME LLC, Montclair, NJ, USA; Manny Papadimitropoulos PhD, Director, Health Outcomes Research, Intercontinental Region and Japan, Eli Lilly Canada Inc., and Assistant Professor, Faculty of Pharmacy, University of Toronto, Toronto, Canada
Course Description: This course will give participants a basic understanding of the key terminology and issues involved in pharmaceutical pricing decisions. It will cover the tools to build and document product value including issues, information and processes employed; the role of pharmacoeconomics and the differences in payment systems that help to shape pricing decisions. These tools will be further explored through a series of interactive exercises. - designed for those with limited experience in the area of pharmaceutical pricing and will cover topics within a global context.
W. Critchley J. Mycka
W. Critchley J. Mycka
M. Papadimitropoulos
M. Papadimitropoulos
   
Pharmacoeconomic Guidelines for Health Care Decision-makers
Faculty: Shanlian Hu MD, MSc, Professor, Training Center for Health Management, School of Public Health, Fudan University, Shanghai, P.R. China; Tony Yen-Huei Tarn MS, PhD, Chairman, College of Pharmacy, Taipei Medical University, Taipei, Taiwan; Alison Tan-Mulligan PhD, MBBS, Health Outcomes & Epidemiology Manager, GlaxoSmithKline Pharmaceuticals (China) Investment Co. Ltd, Shanghai, China.
Course description: Pharmacoeconomic guideline is an analytical tool to assist the establishment of drug formulary, essential drug list and drug reimbursement. Participants will learn the main contents and analytic techniques in pharmacoeconomic guideline, the differences between pharmacoeconomic guidelines around the world and some country-specific pharmacoeconomic guidelines, the political and technical process of its formulation and implementation. These analytical and evidentiary standards can help researchers to conduct pharmcoeconomic evaluation; help drug manufacturers to promote their products in the market and help policy makers to make the decision on drug reimbursement and pricing policies. This course is designed to teach researchers, clinicians, drug manufacturers and policy makers how to understand and use the pharmacoeconomic guidelines from international perspectives, which will be impacted by health system.
S. Hu Y. T. Tarn
S. Hu Y. T. Tarn
   
Reimbursement System and Methodologies
Faculty: Madeleine R. Valera MD, MScIH (Heidelberg), Officer-in-Charge, Health Finance Policy and Services Sector, and Vice President, Quality Assurance Research and Policy Development Group, Philippine Health Insurance Corporation, Pasig City, Philippines; Eduardo Banzon MD, MSc, Senior Health Specialist, World Bank-Manila Office, Manila, Philippines; Christian Gericke MD, MPH, MSc, FAFPHM, Professor and Chair in Public Health Policy, The University of Adelaide, Adelaide, Australia, and Honorary Senior Fellow, European Observatory on Health Systems and Policies.
Course description: This course is designed to provide the participants with understanding of the basic principles of reimbursement systems and methodologies. An overview of main healthcare funding and resource allocation mechanisms for different types of services - hospitals, office-based physicians, and drugs - is given. Recent pharmaceutical spending patterns and trends will be discussed taking account of the wider policy context. A range of cost-containment measures for pharmaceuticals will be presented, with a focus on pharmaceutical pricing strategies. The varying importance of pharmacoeconomics in pharmaceutical reimbursement will be discussed. Participants will have the possibility to apply the course contents in country case studies. Participants will lean about different schemes used by thirdparty payers to make reimbursement decisions. The advantages and disadvantages of different reimbursement mechanisms such as fee-for-service, capitation, managed care, case-based payments (diagnostic related group or DRG) will be presented. The course will also include best practices from different high income countries which could provide lessons for low- and middle-income countries, in particular in Asia. It is the overall objective of the course to make participants aware of the fact that there are no simple, “one size fits all” methods in reimbursing health care providers. This course is designed for those with little experience in pharmaceutical pricing and reimbursement, and is specifically designed for participants who are involved in health financing issues in their daily working environment.
M. Valera E. Banzon
M. Valera E. Banzon
  C. Gericke
  C. Gericke
   

Applied Modeling using Decision Analysis Software TreeAge Pro (Japanese explanation is available if needed)
Faculty: Shu-Chuen Li PhD, MS, MBA, Professor, Chair & Head, Discipline of Pharmacy & Experimental Pharmacology, School of Biomedical Sciences, University of Newcastle, Callaghan NSW, Australia; Noriaki Aoki, MD, PhD, MS, MBA, Assistant Professor, School of Health Information Sciences, The University of Texas Health Science Center at Houston, TX, USA, & President of Center for Health Service, Outcomes Research and Development - Japan (CHORD-J), Tokyo, Japan.
Course description: This course is a hands-on introduction to the use of software in the creation and analysis of cost-effectiveness decision models. The basic techniques for decision tree modeling, simple Markov modeling and Monte Carlo simulation will be introduced. Useful techniques to manage variables and tables in the TreeAge Pro, and to develop Excel dashboard with be demonstrated. This course requires basic understanding of decision analysis. All participants must bring a Windows laptop computer with a copy of TreeAge Pro Suite installed and running and receive a CD-ROM at the training. Download and installation instructions will be provided when you pre-register for the course.

「TreeAge Proによる決断分析モデリング -応用編-」

このコースでは、ソフトウェアを活用した決断分析・費用効果分析のモデリングと分析の方法を実習(hands-
on)形式で学ぶことができます。コースの中では、決断分析・費用効果分析の基礎、シンプルな決断分析樹やマルコフモデルの構築方法、及びモンテ・
カルロシミュレーションモデルによる分析方法が紹介されます。参加者の皆様には、TreeAge Pro Suite がインストールされ、動作の確認がされているWindows PCを持参していただきます。また、会場で実習用のCD-ROMを配布いたします。ソフトウェアのダウンロード及びインストールの方法は、本コースへ仮登録していただいた時点でご連絡いたします。

S. Li N. Aoki
S. Li N. Aoki